Abstract P78
Changes in EMGdi%index, FEV
1
and PEF following 2.5 mg nebulised salbutamol
Asthma (n = 10)
COPD (n = 3)
%reduction EMGdi%index
33.9 (20.6 to 57.6)
22.4 (0.1 to 23.9)
%increase FEV
1
12.5 (0 to 89.0)
−4.4 (−33.3 to −0.9)
%increase PEF
9.25 (−9.9 to –54.2)
0 (−8.6 to 8.3)
Data are presented as median (range).